Back
Biomarin Pharmaceutical Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Buy
62
BMRN
Biomarin Pharmaceutical
Last Price:
$66.64
Seasonality Move:
5.39%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and BMRN is experiencing slight buying pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.87 | Buy |
| 20-day SMA: | 65.82 | Buy |
| 50-day SMA: | 66.54 | Buy |
| 200-day SMA: | 78.72 | Sell |
| 8-day EMA: | 65.99 | Buy |
| 20-day EMA: | 65.87 | Buy |
| 50-day EMA: | 67.53 | Sell |
| 200-day EMA: | 76.81 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 52.97 | Buy |
| Chaikin Money Flow: | 220105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.01 - 66.69) | Buy |
| Bollinger Bands (100): | (63.82 - 83.66) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 66.63 while BMRN 8-day simple moving average is 65.87, which is a Buy signal.
-
The stock price of BMRN is 66.63 while Biomarin Pharmaceutical 20-day SMA is 65.82, which makes it a Buy.
-
Biomarin Pharmaceutical 50-day simple moving average is 66.54 while BMRN share price is 66.63, making it a Buy technically.
-
BMRN stock price is 66.63 and Biomarin Pharmaceutical 200-day simple moving average is 78.72, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
62
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a BuyThe current Biomarin Pharmaceutical [BMRN] share price is $66.63. The Score for BMRN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
12.7B
Price in USD:
66.63
Share Volume:
439K
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.25
52-Week Low:
61.15
Buy
62
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?The Biomarin Pharmaceutical stock price is 66.63 USD today.
-
Will BMRN stock go up or go down?Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Biomarin Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 66.63 while BMRN 8-day exponential moving average is 65.99, which is a Buy signal.
-
The stock price of BMRN is 66.63 while Biomarin Pharmaceutical 20-day EMA is 65.87, which makes it a Buy.
-
Biomarin Pharmaceutical 50-day exponential moving average is 67.53 while BMRN share price is 66.63, making it a Sell technically.
-
BMRN stock price is 66.63 and Biomarin Pharmaceutical 200-day simple moving average is 76.81, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Biomarin Pharmaceutical is a Sell
-
Biomarin Pharmaceutical Relative Strength Index (RSI) is 52.97, which suggest Biomarin Pharmaceutical is overbought
-
The Bollinger Bands (25) for Biomarin Pharmaceutical is (64.01 - 66.69), which suggest Biomarin Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Biomarin Pharmaceutical is (63.82 - 83.66), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.